Fireside Chat: Dissecting the Guidance from Regulatory Bodies to Develop Bacteriophages Likely to Receive Approval
Time: 9:30 am
day: Conference Day One
Details:
- How to use current guidance available from regulatory bodies to drive forward bacteriophage clinical trials
- How to derisk the IND filing process in the absence of clear guidance? What are the expectations of data package submission to minimize potential rejection by FDA?
- How will the live biotic category impact bacteriophages, companies and patients?
